XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.
N
N

Nestle

Texnik xulosa

IndikatorQiymatTrend
IndikatorQiymatTrend
IndikatorQiymatTrend
IndikatorS3S2S1PR1R2R3

Yangiliklar

Reuters - 13 soat oldin

Food companies sell products that are less healthy in poorer countries, says report

UPDATE 1-Food companies sell products that are less healthy in poorer countries, says report Adds comment from Danone, paragraph 12 By Jennifer Rigby LONDON, Nov 7 (Reuters) - The world’s biggest food and beverage companies on average sell products in low-income countries that are less healthy than what they sell in high-income countries, according to a new report.
D
N
P
Reuters - 17 soat oldin

Food companies sell products that are less healthy in poorer countries, says report

Food companies sell products that are less healthy in poorer countries, says report By Jennifer Rigby LONDON, Nov 7 (Reuters) - The world’s biggest food and beverage companies on average sell products in low-income countries that are less healthy than what they sell in high-income countries, according to a new report. Products sold by companies including Nestle NESN.S , Pepsico PEP.O and Unilever ULVR.L were assessed as part of a global index published by the Access to Nutrition Initiative (AT
D
N
P
Reuters - 18 soat oldin

India's Trent posts slowest revenue growth in 14 quarters; shares tumble

India's Trent posts slowest revenue growth in 14 quarters; shares tumble Nov 7 (Reuters) - Indian clothing retailer Trent TREN.NS posted its slowest revenue growth in 14 quarters on Thursday, as consumers in urban pockets grappled with rising cost of living and cut down their spending on non-essential goods. Tata Group-owned Trent posted a 39% a 39% surge in second-quarter revenue to 41.57 billion rupees ($492.8 million), marking its slowest revenue growth since the quarter ended March 2021. "Co
N
H
Reuters - 3 kun oldin

India's Dr Reddy's Q2 profit drops on acquisition cost, impairment charge

UPDATE 2-India's Dr Reddy's Q2 profit drops on acquisition cost, impairment charge Rewrites, adds CFO comment from earnings call By Rishika Sadam and Kashish Tandon HYDERABAD/BENGALURU Nov 5 (Reuters) - Indian generic drugmaker Dr Reddy's Laboratories' REDY.NS second-quarter profit was hit by one-time charges related to its joint venture with Nestle India and Nicotinell acquisition, the company said on Tuesday.
N
Reuters - 4 kun oldin

US CEOs fired more quickly over low stock prices this year, report says

US CEOs fired more quickly over low stock prices this year, report says 42% of S&P 500 companies replacing CEO in 2024 had bottom-quartile returns -Conference Board Boards becoming less patient with undeperformers -report co-author Companies have maintained traditional CEO recruiting patterns -report By Svea Herbst-Bayliss NEW YORK, Nov 4 (Reuters) - U.S.
N
S
U
A

Shartlar

Ommabop aktivlar

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.